Kurome Therapeutics advances with FDA-approved IND for KME-0584 in AML and HR MDS clinical trial

In a significant development for cancer research, Kurome Therapeutics Inc. has announced the U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug ... Read More